Metraipolis › archive › dc_7f37fc263d62

Type I interferon in psoriasis: mechanisms and clinical implications — Europe PMC PMID:42746044

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42746044
DOI
10.3389/fimmu.2026.1924303
License (as archived)
solo-consultazione
Archived
2026-10-16T11:49:58.888Z
SHA-256 of the archived text
e85daa0bb6a7ae10b89b82967de8b0d56c5a1bd21caf5718003457db7e311814
Stable URL of this page
https://metraipolis.com/documento/dc_7f37fc263d62

How to cite

Type I interferon in psoriasis: mechanisms and clinical implications — Europe PMC PMID:42746044 — Europe PMC (en), https://europepmc.org/article/MED/42746044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f37fc263d62 (Metraipolis archive dc_7f37fc263d62, sha256 e85daa0bb6a7ae10b89b82967de8b0d56c5a1bd21caf5718003457db7e311814)
BibTeX
@misc{dc7f37fc263d62,
  title = {Type I interferon in psoriasis: mechanisms and clinical implications — Europe PMC PMID:42746044},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42746044},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f37fc263d62; sha256 e85daa0bb6a7ae10b89b82967de8b0d56c5a1bd21caf5718003457db7e311814},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746044. Agents can read the archived copy with the MCP tool read_document.